Top 5 Stocks to Buy Now
→ My feud with Zohran Mamdani (From Stansberry Research) (Ad)tc pixel Free LFMDP Stock Alerts

LifeMD (LFMDP) Competitors

LifeMD logo
$23.50 0.00 (0.00%)
As of 09:30 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

LFMDP vs. ACONW, DHACW, PIIIW, TALKW, and TOIIW

Should you buy LifeMD stock or one of its competitors? MarketBeat compares LifeMD with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with LifeMD include Aclarion (ACONW), Digital Health Acquisition (DHACW), P3 Health Partners (PIIIW), Talkspace (TALKW), and Oncology Institute (TOIIW). These companies are all part of the "healthcare" industry.

How does LifeMD compare to Aclarion?

Aclarion (NASDAQ:ACONW) and LifeMD (NASDAQ:LFMDP) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, earnings and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
AclarionN/A N/A N/A
LifeMD N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aclarion$77.88KN/AN/AN/AN/A
LifeMD$193.33MN/AN/AN/AN/A

In the previous week, LifeMD had 3 more articles in the media than Aclarion. MarketBeat recorded 3 mentions for LifeMD and 0 mentions for Aclarion. LifeMD's average media sentiment score of 0.33 beat Aclarion's score of 0.00 indicating that LifeMD is being referred to more favorably in the news media.

Company Overall Sentiment
Aclarion Neutral
LifeMD Neutral

Summary

LifeMD beats Aclarion on 3 of the 3 factors compared between the two stocks.

How does LifeMD compare to Digital Health Acquisition?

LifeMD (NASDAQ:LFMDP) and Digital Health Acquisition (NASDAQ:DHACW) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, media sentiment, analyst recommendations, risk, dividends and valuation.

In the previous week, LifeMD had 3 more articles in the media than Digital Health Acquisition. MarketBeat recorded 3 mentions for LifeMD and 0 mentions for Digital Health Acquisition. LifeMD's average media sentiment score of 0.33 beat Digital Health Acquisition's score of 0.00 indicating that LifeMD is being referred to more favorably in the media.

Company Overall Sentiment
LifeMD Neutral
Digital Health Acquisition Neutral

Company Net Margins Return on Equity Return on Assets
LifeMDN/A N/A N/A
Digital Health Acquisition N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeMD$193.33MN/AN/AN/AN/A
Digital Health AcquisitionN/AN/AN/AN/AN/A

Summary

LifeMD beats Digital Health Acquisition on 3 of the 3 factors compared between the two stocks.

How does LifeMD compare to P3 Health Partners?

LifeMD (NASDAQ:LFMDP) and P3 Health Partners (NASDAQ:PIIIW) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership and profitability.

In the previous week, LifeMD had 3 more articles in the media than P3 Health Partners. MarketBeat recorded 3 mentions for LifeMD and 0 mentions for P3 Health Partners. LifeMD's average media sentiment score of 0.33 beat P3 Health Partners' score of 0.00 indicating that LifeMD is being referred to more favorably in the media.

Company Overall Sentiment
LifeMD Neutral
P3 Health Partners Neutral

Company Net Margins Return on Equity Return on Assets
LifeMDN/A N/A N/A
P3 Health Partners N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeMD$193.33MN/AN/AN/AN/A
P3 Health Partners$1.47BN/AN/AN/AN/A

Summary

LifeMD beats P3 Health Partners on 2 of the 3 factors compared between the two stocks.

How does LifeMD compare to Talkspace?

Talkspace (NASDAQ:TALKW) and LifeMD (NASDAQ:LFMDP) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, media sentiment, profitability, valuation, earnings, risk and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Talkspace$238.37MN/AN/AN/AN/A
LifeMD$193.33MN/AN/AN/AN/A

In the previous week, LifeMD had 3 more articles in the media than Talkspace. MarketBeat recorded 3 mentions for LifeMD and 0 mentions for Talkspace. LifeMD's average media sentiment score of 0.33 beat Talkspace's score of 0.00 indicating that LifeMD is being referred to more favorably in the news media.

Company Overall Sentiment
Talkspace Neutral
LifeMD Neutral

Company Net Margins Return on Equity Return on Assets
TalkspaceN/A N/A N/A
LifeMD N/A N/A N/A

Summary

LifeMD beats Talkspace on 2 of the 3 factors compared between the two stocks.

How does LifeMD compare to Oncology Institute?

LifeMD (NASDAQ:LFMDP) and Oncology Institute (NASDAQ:TOIIW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, earnings, risk, valuation, institutional ownership and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeMD$193.33MN/AN/AN/AN/A
Oncology Institute$545.76MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
LifeMDN/A N/A N/A
Oncology Institute N/A N/A N/A

In the previous week, LifeMD had 3 more articles in the media than Oncology Institute. MarketBeat recorded 3 mentions for LifeMD and 0 mentions for Oncology Institute. LifeMD's average media sentiment score of 0.33 beat Oncology Institute's score of 0.00 indicating that LifeMD is being referred to more favorably in the media.

Company Overall Sentiment
LifeMD Neutral
Oncology Institute Neutral

Summary

LifeMD beats Oncology Institute on 2 of the 3 factors compared between the two stocks.

Get LifeMD News Delivered to You Automatically

Sign up to receive the latest news and ratings for LFMDP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LFMDP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LFMDP vs. The Competition

Export
MetricLifeMDHealth Information Services IndustryMedical SectorNASDAQ Exchange
Market CapN/A$354.28M$6.55B$12.20B
Dividend Yield11.99%5.60%2.69%5.82%
P/E RatioN/A251.0925.1824.19
Price / SalesN/A131.22554.67122.21
Price / CashN/A47.1444.8254.51
Price / BookN/A7.2110.826.51
Net IncomeN/A-$22.78M$3.56B$337.14M
7 Day Performance-1.38%-0.28%1.98%0.26%
1 Month Performance-0.53%1.91%1.43%1.22%
1 Year Performance-2.71%-10.57%31.13%28.88%

LifeMD Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LFMDP
LifeMD
N/A$23.50
flat		N/A-2.3%$0.00$193.33MN/A230
ACONW
Aclarion
N/A$0.03
-9.2%		N/A-29.4%$0.00$77.88KN/A7
DHACW
Digital Health Acquisition
N/A$0.03
flat		N/AN/A$0.00N/AN/AN/A
PIIIW
P3 Health Partners
N/A$0.01
-19.0%		N/A+51.1%$0.00$1.47BN/A500
TALKW
Talkspace
N/A$0.00
-27.9%		N/A-98.5%$0.00$238.37MN/A500

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:LFMDP) was last updated on 6/24/2026 by MarketBeat.com Staff.
From Our Partners
Four winners over 400%. Here's #5
CFA and CMT analyst Garrett Goggin called G2 Goldfields before it rose 1,023%, Reunion Gold before 538%, Highl...
Golden Portfolio | Sponsoredtc pixel
My feud with Zohran Mamdani
Nearly 40% of Americans now hold a positive view of socialism - and former hedge fund manager Whitney Tilson s...
Stansberry Research | Sponsoredtc pixel
BlackRock's CEO is calling this "the next major evolution"
Larry Fink, CEO of BlackRock - the world's largest asset manager with $10 trillion under management - is calli...
Awesomely, LLC | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Top Banks Warn: A Strange Day is Coming to America
Goldman Sachs and Morgan Stanley are warning clients about a developing crisis that could suppress portfolio g...
TradeSmith | Sponsoredtc pixel
A drilling crew just broke a record nobody expected
A drilling crew in Beaver County, Utah hit 15,765 feet of solid granite in 16 days - a job the Department of E...
Behind the Markets | Sponsoredtc pixel
Karp just filed Form 144
On May 12, 2026, Palantir CEO Alex Karp filed to sell 585,000 shares - roughly $95.93 million. Combined with f...
Porter & Company | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel